The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I and II, with some 3,4-dihydroxypyrrolidine-2,5-dione and 3,5-dihydroxybenzoic acid derivatives, were investigated by using the esterase assay, with 4-nitrophenyl acetate (4-NPA) as substrate. Compounds 10-13 showed KI values in the range of 112.7-441.5 μM for hCA I and of 3.5-10.76 μM against hCA II, respectively. These hydroxyl group containing compounds generally were competitive inhibitors. Some hydroxyl group containing compounds investigated here showed effective hCA II inhibitory effects, in the same range as the clinically used sulfonamide acetazolamide, and might be used as leads for generating enzyme inhibitors possibly targeting other CA isoforms which have not been yet assayed for their interactions with such agents.

Download full-text PDF

Source
http://dx.doi.org/10.3109/14756366.2014.983917DOI Listing

Publication Analysis

Top Keywords

34-dihydroxypyrrolidine-25-dione 35-dihydroxybenzoic
8
35-dihydroxybenzoic acid
8
acid derivatives
8
carbonic anhydrase
8
μm hca
8
hydroxyl group
8
group compounds
8
synthesis 34-dihydroxypyrrolidine-25-dione
4
derivatives evaluation
4
evaluation carbonic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!